ClinicalTrials.Veeva

Menu

Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever

I

Istanbul University - Cerrahpasa

Status

Completed

Conditions

Healty Controls
Familial Mediterranean Fever
Juvenile Idiopathic Arthritis

Treatments

Other: Usability and Comparison

Study type

Observational

Funder types

Other

Identifiers

NCT06697028
AAlbayrak

Details and patient eligibility

About

Juvenile Idiopathic Arthritis (JIA) and Familial Mediterranean Fever (FMF) are the most common autoimmune and autoinflammatory rheumatic diseases in childhood. Symptoms such as reduced muscle strength, joint pain, fatigue, and limited activity, which are common in childhood rheumatic diseases, often lead to impaired physical function. Cardiorespiratory fitness, which is an important indicator of physical function, plays a critical role in health-related outcomes in children and adolescents with rheumatic disease. Maximum oxygen consumption (VO2 peak) is considered the fundamental criterion for evaluating cardiorespiratory fitness. The need for extensive equipment and trained personnel, accompanied with the inability to assess large numbers of children at one-time makes the objective assessment of cardiorespiratory fitness in a clinic setting unmanageable. Therefore, there is a need to assess their cardiorespiratory fitness utilizing an easily administered test that has minimal measurement errors in patients with JIA and FMF. The Progressive Aerobic Cardiovascular Endurance Run (PACER) has become a routine cardiorespiratory fitness assessment for predicting VO2peak in children. A review of the literature revealed that no studies have evaluated CRF using PACER in childhood rheumatic diseases. The aim of this study was to compare the Fitnessgram VO2 max values of children and adolescents diagnosed with JIA and FMF with those of their healthy peers and to examine the relationship with body composition.

Enrollment

216 patients

Sex

All

Ages

12 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Did not have any chronic disease other than rheumatic disease
  • Diagnosed with rheumatic disease at least 6 months ago
  • Had stable medical treatment
  • Being between the ages of 12 and 18
  • Volunteering to participate in the study

Exclusion criteria

  • Have experienced trauma or surgery affecting the musculoskeletal system within the last 6 months
  • Have acute pain for any reason, have visual or hearing problems
  • Have cognitive impairment
  • Not volunteering to participate in the study

Trial design

216 participants in 3 patient groups

Juvenile Idiopathic Arthritis
Description:
Patients diagnosed with JIA followed at the Pediatric Rheumatology Clinic, Department of Pediatrics, Istanbul Faculty of Medicine, will be evaluated.
Treatment:
Other: Usability and Comparison
Familial Mediterranean Fever
Description:
Patients diagnosed with FMF followed at the Pediatric Rheumatology Clinic, Department of Pediatrics, Istanbul Faculty of Medicine, will be evaluated.
Treatment:
Other: Usability and Comparison
Healthy control
Description:
The outcomes of individuals with rheumatic diseases will be compared with those of healthy controls.
Treatment:
Other: Usability and Comparison

Trial contacts and locations

1

Loading...

Central trial contact

Nilay Arman, PhD; Asya Albayrak, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems